You are here

  • Home
  • Archive
  • Volume 81, Issue 2
  • Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide

Article Text

Article menu
Download PDFPDF
Original Article
Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide
  1. James T Rosenbaum,
  2. Jennifer Simpson,
  3. C Michael Neuwelt
  1. Oregon Health Sciences University, Casey Eye Institute, Portland, Oregon, USA
  1. J T Rosenbaum, MD, Oregon Health Sciences University, Casey Eye Institute, 3375 SW Terwilliger Blvd, Portland, OR 97201, USA.

Abstract

BACKGROUND Optic neuropathy is a rare manifestation of systemic lupus erythematosus (SLE). In a previous series most patients with optic neuropathy in association with SLE had a final visual acuity of 20/200 or less despite corticosteroid therapy.

METHODS Three patients (five affected eyes) with severe retrobulbar optic neuropathy in association with SLE were treated promptly with intravenous cyclophosphamide and corticosteroids.

RESULTS All patients recovered excellent visual acuity.

CONCLUSION Although optic neuropathy in association with SLE might have several different aetiologies, intravenous cyclophosphamide should be strongly considered as a therapeutic alternative.

  • optic neuropathy
  • systemic lupus erythematosus
  • cyclophosphamide

https://doi.org/10.1136/bjo.81.2.130

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes